Vitamin D3-driven Signals for Myeloid Cell Differentiation--implications for Differentiation Therapy

Overview

Journal Leuk Res

Date 2009 Oct 9

PMID 19811822

Citations 33

Authors

Philip J Hughes

Ewa Marcinkowska

Elzbieta Gocek

George P Studzinski

Geoffrey Brown

Affiliations

Soon will be listed here.

Abstract

Primitive myeloid leukemic cell lines can be driven to differentiate to monocyte-like cells by 1alpha,25-dihydroxyvitamin D(3) (1,25(OH)(2)D(3)), and, therefore, 1,25(OH)(2)D(3) may be useful in differentiation therapy of myeloid leukemia and myelodysplastic syndromes (MDS). Recent studies have provided important insights into the mechanism of 1,25(OH)(2)D(3)-stimulated differentiation. For myeloid progenitors to complete monocytic differentiation a complex network of intracellular signals has to be activated and/or inactivated in a precise temporal and spatial pattern. 1,25(OH)(2)D(3) achieves this change to the 'signaling landscape' by (i) direct genomic modulation of the level of expression of key regulators of cell signaling and differentiation pathways, and (ii) activation of intracellular signaling pathways. An improved understanding of the mode of action of 1,25(OH)(2)D(3) is facilitating the development of new therapeutic regimens.

Citing Articles

Impact of Serum Ferritin and Iron Overload on Acute Myeloid Leukemia Outcomes: A Systematic Review and Meta-Analysis.

Sadighi S, Sahinoglu E, Haider Kubba A, Patel J, Hosseini S, Shafiee M Asian Pac J Cancer Prev. 2024; 25(8):2951-2962.

PMID: 39205594 PMC: 11495433. DOI: 10.31557/APJCP.2024.25.8.2951.

A Systematic Review Assessing the Impact of Vitamin D Levels on Adult Patients with Lymphoid Malignancies.

Potre C, Borsi E, Potre O, Ionita I, Samfireag M, Costachescu D Curr Oncol. 2023; 30(4):4351-4364.

PMID: 37185444 PMC: 10137018. DOI: 10.3390/curroncol30040331.

Targeting myeloid-derived suppressor cells in tumor immunotherapy: Current, future and beyond.

Zhao Y, Du J, Shen X Front Immunol. 2023; 14:1157537.

PMID: 37006306 PMC: 10063857. DOI: 10.3389/fimmu.2023.1157537.

Targeting the Tumor Microenvironment in Acute Myeloid Leukemia: The Future of Immunotherapy and Natural Products.

Hino C, Pham B, Park D, Yang C, Nguyen M, Kaur S Biomedicines. 2022; 10(6).

PMID: 35740430 PMC: 9219790. DOI: 10.3390/biomedicines10061410.

Role for Fgr and Numb in retinoic acid-induced differentiation and G0 arrest of non-APL AML cells.

Kazim N, Yen A Oncotarget. 2021; 12(12):1147-1164.

PMID: 34136084 PMC: 8202776. DOI: 10.18632/oncotarget.27969.

References

Lajdova I, Chorvat Jr D, Chorvatova A . Rapid effects of 1alpha,25(OH)2D3 in resting human peripheral blood mononuclear cells. Eur J Pharmacol. 2008; 586(1-3):14-23. DOI: 10.1016/j.ejphar.2008.02.004. View

Wu-Wong J, Nakane M, Ma J, Dixon D, Gagne G . Vitamin D receptor (VDR) localization in human promyelocytic leukemia cells. Leuk Lymphoma. 2006; 47(4):727-32. DOI: 10.1080/10428190500398898. View

Stone R, Weber B, Spriggs D, Kufe D . Phospholipase C activates protein kinase C and induces monocytic differentiation of HL-60 cells. Blood. 1988; 72(2):739-44. View

Kang S, Lee M, Kim K, Cho D, Kim T . Induction of human promyelocytic leukemia HL-60 cell differentiation into monocytes by silibinin: involvement of protein kinase C. Biochem Pharmacol. 2001; 61(12):1487-95. DOI: 10.1016/s0006-2952(01)00626-8. View

Moeenrezakhanlou A, Nandan D, Reiner N . Identification of a calcitriol-regulated Sp-1 site in the promoter of human CD14 using a combined western blotting electrophoresis mobility shift assay (WEMSA). Biol Proced Online. 2008; 10:29-35. PMC: 2275043. DOI: 10.1251/bpo140. View

Koeffler H, Hirji K, Itri L . 1,25-Dihydroxyvitamin D3: in vivo and in vitro effects on human preleukemic and leukemic cells. Cancer Treat Rep. 1985; 69(12):1399-407. View

Okazaki T, Bell R, Hannun Y . Sphingomyelin turnover induced by vitamin D3 in HL-60 cells. Role in cell differentiation. J Biol Chem. 1989; 264(32):19076-80. View

Carlberg C, Dunlop T, Saramaki A, Sinkkonen L, Matilainen M, Vaisanen S . Controlling the chromatin organization of vitamin D target genes by multiple vitamin D receptor binding sites. J Steroid Biochem Mol Biol. 2007; 103(3-5):338-43. DOI: 10.1016/j.jsbmb.2006.12.044. View

Shahjahan M, Dunphy C, Ewton A, Zu Y, Monzon F, Rice L . p38 mitogen-activated protein kinase has different degrees of activation in myeloproliferative disorders and myelodysplastic syndromes. Am J Clin Pathol. 2008; 130(4):635-41. DOI: 10.1309/2450EGK3V0XK8D9D. View

10.

Abe E, Miyaura C, Sakagami H, Takeda M, Konno K, Yamazaki T . Differentiation of mouse myeloid leukemia cells induced by 1 alpha,25-dihydroxyvitamin D3. Proc Natl Acad Sci U S A. 1981; 78(8):4990-4. PMC: 320317. DOI: 10.1073/pnas.78.8.4990. View

11.

Ji Y, Wang X, Donnelly R, Uskokovic M, Studzinski G . Signaling of monocytic differentiation by a non-hypercalcemic analog of vitamin D3, 1,25(OH)2-5,6 trans-16-ene-vitamin D3, involves nuclear vitamin D receptor (nVDR) and non-nVDR-mediated pathways. J Cell Physiol. 2002; 191(2):198-207. DOI: 10.1002/jcp.10091. View

12.

Bozulic L, Hemmings B . PIKKing on PKB: regulation of PKB activity by phosphorylation. Curr Opin Cell Biol. 2009; 21(2):256-61. DOI: 10.1016/j.ceb.2009.02.002. View

13.

Fazi F, Rosa A, Fatica A, Gelmetti V, De Marchis M, Nervi C . A minicircuitry comprised of microRNA-223 and transcription factors NFI-A and C/EBPalpha regulates human granulopoiesis. Cell. 2005; 123(5):819-31. DOI: 10.1016/j.cell.2005.09.023. View

14.

Seibenhener M, Wooten M . Heterogeneity of protein kinase C isoform expression in chemically induced HL60 cells. Exp Cell Res. 1993; 207(1):183-8. DOI: 10.1006/excr.1993.1178. View

15.

Honda A, Raz A, NEEDLEMAN P . Induction of cyclo-oxygenase synthesis in human promyelocytic leukaemia (HL-60) cells during monocytic or granulocytic differentiation. Biochem J. 1990; 272(1):259-62. PMC: 1149687. DOI: 10.1042/bj2720259. View

16.

Moeenrezakhanlou A, Shephard L, Lam L, Reiner N . Myeloid cell differentiation in response to calcitriol for expression CD11b and CD14 is regulated by myeloid zinc finger-1 protein downstream of phosphatidylinositol 3-kinase. J Leukoc Biol. 2008; 84(2):519-28. DOI: 10.1189/jlb.1207833. View

17.

Marcinkowska E, Kutner A . Side-chain modified vitamin D analogs require activation of both PI 3-K and erk1,2 signal transduction pathways to induce differentiation of human promyelocytic leukemia cells. Acta Biochim Pol. 2002; 49(2):393-406. View

18.

Hawkins P, Anderson K, Davidson K, Stephens L . Signalling through Class I PI3Ks in mammalian cells. Biochem Soc Trans. 2006; 34(Pt 5):647-62. DOI: 10.1042/BST0340647. View

19.

Racanicchi S, Maccherani C, Liberatore C, Billi M, Gelmetti V, Panigada M . Targeting fusion protein/corepressor contact restores differentiation response in leukemia cells. EMBO J. 2005; 24(6):1232-42. PMC: 556397. DOI: 10.1038/sj.emboj.7600593. View

20.

Lee R, Ambros V . An extensive class of small RNAs in Caenorhabditis elegans. Science. 2001; 294(5543):862-4. DOI: 10.1126/science.1065329. View